CLINICAL CORE

临床核心

• 批准号: 10415890
• 负责人: Anna Halina Nowak-Wegrzyn
• 金额: $ 53.61万
• 依托单位: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-06-06 至 2023-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10415890
• 关键词: Affect; Allergens; Allergy to eggs; Allergy to peanuts; Arachis hypogaea; Archives; Biological Markers; Child; Clinical; Communication; Data; Dietitian; Disease; Disease Outcome; Ensure; Epinephrine; Evaluation; Food Hypersensitivity; Grant; Health; Heart; Heterogeneity; Human Resources; Immune; Ingestion; Institutional Review Boards; Interdisciplinary Study; Laboratories; Link; Methods; Milk; Milk Hypersensitivity; Molecular; Monitor; National Institute of Allergy and Infectious Disease; Nurses; Outcome; Performance; Periodicity; Pharmaceutical Preparations; Pharmacy facility; Phenotype; Population; Protocols documentation; Quality of life; Randomized Controlled Clinical Trials; Research; Research Personnel; Resolution; Resources; Safety; Sampling; Scientist; Site; Site Visit; Specimen; Speed; Symptoms; System; United States National Institutes of Health; Withdrawal; base; cost; data management; data sharing; dietary; economic impact; egg; experience; high dimensionality; human subject; improved; innovation; interest; international center; medical schools; programs; public database; quality assurance; recruit; repository; transcriptome sequencing

Project Summary-Clinical Core The Clinical Core will provide pesonnel and resources for safe and effective conduct of the CAFETERIA trial, including ensuring that bio-specimens are provided for Projects 2 and 3 in this program. The Clinical Core will also establish independent monitoring of the study, ensure appropriate human subjects safeguards, and promote communication among the trial investigators, the DSCC, DAIT-DSMB and NIAID project scientists.

项目概要-临床核心 临床核心将为安全有效地进行 CAFETERIA 试验提供人员和资源， 包括确保为本计划中的项目 2 和 3 提供生物样本。临床核心将 还建立对研究的独立监测，确保适当的人类受试者保障措施，以及 促进试验研究者、DSCC、DAIT-DSMB 和 NIAID 项目科学家之间的沟通。